Healio Rheumatology


The following articles appeared in the print edition of HEALIO RHEUMATOLOGY.

Table of Contents
By the Numbers

Six Top Stories From the EULAR Annual Congress

Cover Story

Big Data: What Every Rheumatologist Should Know

Drug Pipeline

EMA to Review Marketing Authorization Application of Biosimilar to Candidate to Humira

Subcutaneous Abatacept Now Available for Patients With JIA

Proposed Biosimilars to Humira, Remicade Accepted for Review by EMA


Big Data in Rheumatology: Is it a Cautionary Note?

Leonard H. Calabrese, DO


AAHKS, ACR Release Guidelines for Management of Antirheumatic Drugs for Patients Who Undergo TKA, THA

ACR Issues Statement After FDA Releases Guidance on Biosimilar Interchangeability

In the Journals

Nail Findings Distinguish Between Psoriasis, Psoriatic Arthritis

State Medical Licensing Board Questions May Discourage Physicians From Addressing Their Mental Health

Study: Fibromyalgia May Mask Axial Spondyloarthritis

Greater Fish Consumption Linked to Lower RA Disease Activity

Adalimumab Biosimilar Showed Similar Safety, Efficacy as Reference Product in Patients With RA

Both HA and PRP Linked With Significantly Improved Pain Relief in Patients With Knee OA

Meeting News

Early Intervention May Reduce Onset of RA

Study Finds FKB327 Non-inferior to Adalimumab Regarding Pharmacokinetics, Safety

Nailfold Videocapillaroscopy May Aid in Early Diagnosis of Systemic Sclerosis

Romosozumab Reduced Vertebral Fracture Risk in Older Women With Osteoporosis

Long-term Hydroxychloroquine Therapy May Reduce Cardiovascular Events in SLE

Q&A With Healio Rheumatology

New Generation of Rheumatologists Needed to Meet Future Demand

Trend Watch

Supreme Court Ruling Accelerates Availability of Biosimilars